ERBB2 Amplification and HER2 Expression in Salivary Duct Carcinoma: Evaluation of Scoring Guidelines and Potential for Expanded Anti-HER2 Therapy-Reference-Cited by-同舟云学术

ERBB2 Amplification and HER2 Expression in Salivary Duct Carcinoma: Evaluation of Scoring Guidelines and Potential for Expanded Anti-HER2 Therapy

Published:2023-10 Issue:10 Volume:36 Page:100273
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Modern Pathology

Author:

McAfee John L.^ORCID,Hoda Raza S.,Hoyle Carrie,McCoy Lauren,Sprague Cathy,Reddy Chandana A.,Koyfman Shlomo A.,Geiger Jessica L.,Komforti Miglena K.,Griffith Christopher C.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference56 articles.

1. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: analysis of 228 cases from the Surveillance, Epidemiology, and End Results database;Jayaprakash;Head Neck,2014

2. Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: a nationwide case series of 35 patients in The Netherlands;Boon;Head Neck,2018

3. A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma;Fushimi;Ann Oncol,2018

4. Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma;Takahashi;J Clin Oncol,2019

5. Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas;Park;Head Neck,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERBB2/ ERBB3-mutated S100/ SOX10-positive unclassified high-grade uterine sarcoma: first detailed description of a novel entity;Virchows Archiv;2024-08-28

2. Immunohistochemistry Screening of Different Tyrosine Kinase Receptors in Canine Solid Tumors—Part I: Proposal of a Receptor Panel to Predict Therapies;International Journal of Molecular Sciences;2024-08-02

3. High-grade salivary carcinomas: A current insight on diagnostic pathology and the key to clinical decision making;Seminars in Diagnostic Pathology;2024-07

4. Salivary duct carcinoma with squamous differentiation: histomorphological and immunophenotypical analysis of six cases;Histopathology;2024-06-03

5. Oncocytoid Salivary Tumors: Differential Diagnosis and Utility of Newly Described Immunohistochemistry;Head and Neck Pathology;2024-03-19